Frank L. Douglas Ph.D., M.D.
An award-winning industry veteran with more than three decades of experience in healthcare, pharmaceuticals and entrepreneurship, Douglas has held leadership roles in both large and small biopharmaceutical companies. He led teams that were responsible for the development and marketing approval of many drugs, including Allegra, Lantus, Taxotere and Actonel.
Douglas has also held several academic positions. While at Massachusetts Institute of Technology (MIT), Douglas was the Professor of the Practice in the MIT Sloan School of Management and also held similar appointments in the departments of Biology, Biological Engineering, and the Harvard-MIT Division of Health Sciences and Technology and was the founder and first executive director of the MIT Center for Biomedical Innovation.
Awards And Honors
Douglas is the recipient of the 2007 Black History Makers Award and has been honored twice as the Global Pharmaceutical R&D Director of the Year, in recognition of his leadership and success in improving innovation and productivity in pharmaceutical companies. He has also received the Medal of Honor and an Honorary Professorship from the Johann Wolfgang von Goethe University in Frankfurt, Germany. He was honored as one of Geoffrey Beene Gives Back® and GQ Magazine’s 2010 Rock Stars of Science™, and received the Caribbean Luminary Award from the American Foundation for The University of the West Indies and the Executive of the Year Award from the local affiliate of Sales and Marketing Executives International. Other awards include the NOBCChe Lifetime Achievement Award and the Louis B. Russell Memorial American Heart Association Award.
Douglas holds a BS in Chemistry from Lehigh University, Ph.D. in Physical Chemistry and a M.D. from Cornell University. He did his internship and residency in internal medicine at the Johns Hopkins Medical Institution and a fellowship in neuroendocrinology at the National Institutes of Health.